Medications

FDA panel rejects combination pain pill

Federal health advisers have unanimously rejected an experimental pain pill that combines two common opioids, oxycodone and morphine.

Neuroscience

Study identifies new drug target for chronic, touch-evoked pain

(Medical Xpress)—Researchers at the School of Medicine have identified a subset of nerve cells that mediates a form of chronic, touch-evoked pain called tactile allodynia, a condition that is resistant to conventional pain ...

Surgery

Gabapentin doesn't cut use of morphine post-knee arthroplasty

(HealthDay)—The addition of gabapentin to patient-controlled analgesia (PCA) protocol does not reduce morphine consumption, pain, or opioid-related side effects in patients undergoing total knee arthroplasty, according ...

page 5 from 13